ALPINE IMMUNE SCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q1 2024.
  • Alpine Immune Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$17.9M, a 35.1% decline year-over-year.
  • Alpine Immune Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$36.8M, a 42% increase year-over-year.
  • Alpine Immune Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.2M, a 44.3% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$57.8M, a 14.8% decline from 2021.
  • Alpine Immune Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$50.3M, a 80.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$36.8M -$17.9M -$4.65M -35.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$32.2M $5.96M +$24.8M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$57M -$11.7M +$1.55M +11.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$58.6M -$13.2M +$4.94M +27.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-14
Q1 2023 -$63.5M -$13.3M -$5.74M -76.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$57.8M -$18.9M -$3.7M -24.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$54.1M -$13.3M +$221K +1.64% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$54.3M -$18.1M -$7.07M -64.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$47.2M -$7.53M +$3.12M +29.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$50.3M -$15.2M -$8.83M -139% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-20
Q3 2021 -$41.5M -$13.5M -$7.36M -120% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$34.2M -$11M -$1.1M -11.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$33.1M -$10.6M -$5.11M -92.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$27.9M -$6.34M -$202K -3.29% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$27.7M -$6.14M +$5.34M +46.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$33.1M -$9.93M +$1.93M +16.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$35M -$5.53M +$6.85M +55.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$41.9M -$6.14M +$5M +44.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 -$46.8M -$11.5M +$664K +5.47% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$47.5M -$11.9M -$3.95M -49.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$43.6M -$12.4M -$7.08M -133% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$36.5M -$11.1M -$6.82M -158% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 -$29.7M -$12.1M -$14.3M -672% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$15.4M -$7.91M -$4.31M -120% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$11.1M -$5.31M -$3.32M -167% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$7.78M -$4.32M +$3.4M +44% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 -$11.2M $2.12M +$2.5M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$13.7M -$3.6M +$4.88M +57.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$18.6M -$1.99M +$5.85M +74.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$24.4M -$7.71M -$1.15M -17.5% Oct 1, 2016 Dec 31, 2016 10-K 2017-02-13
Q3 2016 -$23.3M -$374K +$5.72M +93.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$29M -$8.48M -$2.63M -44.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-21
Q1 2016 -$26.3M -$7.84M -$3.52M -81.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$22.8M -$6.56M -$3.08M -88.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-13
Q3 2015 -$19.7M -$6.09M -$3.46M -131% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-13
Q2 2015 -$16.3M -$5.85M -$1.66M -39.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-13
Q1 2015 -$14.6M -$4.31M +$36K +0.83% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-13
Q4 2014 -$14.7M -$3.49M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$2.63M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$4.19M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 -$4.35M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.